Contrasting Effects of Type I Interferon as a Mucosal Adjuvant for Influenza Vaccine in Mice and Humans

To identify an adjuvant that enhances antibody responses in respiratory secretions to inactivated influenza virus vaccine (IVV), a comparison was made of responses to intranasal vaccinations of mice with IVV containing monophosphoryl lipid A (MPL), type I interferon (IFN) or cholera toxin B (CTB). A...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Couch, Robert B., Atmar, Robert L., Cate, Thomas R., Quarles, John M., Keitel, Wendy A., Arden, Nancy H., Wells, Janet, Niño, Diane, Wyde, Philip R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778204/
https://ncbi.nlm.nih.gov/pubmed/19607949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.06.084
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky